Live Courses

June 16-24, 2026 NAPLEX & Clinical CPJE, 7-day Live Virtual Board Review

Course Information

Structure

What's included:

• Live Instruction: 56 hours of High-yield Clinical Review

• Coursebook: 700 pages of focused material (delivered within 5–7 business days)

• Question Bank: 6-month access to 2,500 questions with detailed explanations

• Practice Exams: Two full-length (100-question) exams

• Chart Book: A concise 100-page Chartbook for memorizing essential details

• Support: Direct access to expert instructors, Dr. Yavari & Dr. Miremadi, via email
  

Important Notes:

• Due to time constraints, not all topics will be covered live. FOR FULL COVERAGE, we recommend the BUNDLE COURSE, which includes the attendance of the 7-Day review PLUS 6-month access to pre-recorded lessons on ALL TOPICS.

• To get the most out of the live class, reviewing the online course videos (included with the BUNDLE course) beforehand is highly recommended, but not required.

• The course covers clinical content only (NO LAW). CPJE law is offered separately.

Schedule (PST):

June 16 - 24, 2026                   Live course dates & hours (PST):
June 16 (Tuesday)                    8 AM - 5 PM Pacific Standard Time 
June 17 (Wednesday)               8 AM - 5 PM Pacific Standard Time 
June 18 (Thursday)                   8 AM - 5 PM Pacific Standard Time 
June 19 (Friday)                        8 AM - 5 PM Pacific Standard Time 
June 20 (Saturday OFF)            NO CLASS 
June 21 (Sunday OFF)              NO CLASS           
June 22 (Monday)                      8 AM - 5 PM Pacific Standard Time 
June 23 (Tuesday)                     8 AM - 5 PM Pacific Standard Time
June 24 (Wednesday)                8 AM - 5 PM Pacific Standard Time

Registration Deadline: To ensure timely delivery of coursebooks, please register by June 8, 2026. Late registrations may result in coursebooks arriving after the course begins.

Class Rescheduling: Registrants can reschedule their live class to a future date by emailing us after registration. Board review classes are non-refundable.

Clinical-Only Focus: The 7-day live board review focuses exclusively on clinical pharmacy lectures for NAPLEX® and the clinical portion of CPJE. The law portion of the CPJE is NOT included and is covered separately by the CA Law Online Course.

Access Restrictions: Participants may join live virtual sessions only from within the U.S. and its territories.

User Dashboard Quiz Bank Demo View Topics

6-month access to Online Question Bank is included with the Live course: 2500 Board-type questions with answers, detailed explanations & patient profile cases to solidify your understanding of the material. 

The questions are formatted to include patient profiles, fill-in-the-blank calculations, and standard multiple-choice questions. 

Progress Tracking allows you to follow and manage your question bank results and evaluate your progress on your user dashboard. At the end of your study, we have two comprehensive practice tests to conclude the material covered. 

Sample

Start Over Retake Quiz

Case:

RN, a 56-year-old male patient, presents to the ER with progressively worsening shortness of breath when walking more than 20 feet, fatigue, and bilateral pitting edema of his legs for the last few months.

Past Medical History:
DM type 2
Long-standing hypertension

Current Medications:
Metformin 1000 mg PO BID
Pioglitazone 30 mg PO once daily
Hydrochlorothiazide 25 mg PO once daily
Lisinopril 40 mg PO once daily
Amlodipine 10 mg PO once daily

Vitals:  BP: 110/63 mmHg    P: 110,    Resp Rate: 22    Temp: 97.8

Labs:
BUN  ................................   19 mg/dL (6-20)
Serum Creatinine .............    1.1 mg/dL (0.6-1.2)
Potassium .......................     3.1 mEq/L (3.5-5.2)
BNP ................................     960 (10-300)
Troponins .......................     Negative

Imaging Studies:
Chest x-ray: Enlarged cardiac silhouette, mild pulmonary edema
Echocardiogram: Ejection Fraction: 30%

---

Question:

Which of his medications may be worsening his pulmonary edema and leg edema symptoms? Select ALL that apply.

Answer:

A Metformin B Poiglitazone C Hydrochlorothiazide D Lisinopril E Amlodipine

Submit Answer

Case:

MK is a 49-year-old male with history of liver cirrhosis. He is brought to ER by family members with a chief complaint of confusion and altered mental status for the last 24 hours.

On exam, MK is difficult to arouse; he is not oriented to time, person or place.

Vitals:   BP: 110/67 mmHg       P: 80          RR: 14       Temp 98.6

Labs:

Comprehensive Metabolic Panel:

	Normal Range	Results
Sodium	135 – 145 mEq/L	138
Potassium	3.5 – 5.2 mEq/L	4.2
Chloride	97 – 108 mEq/L	100
HCO3	23 – 29 mEq/L	25
Calcium	8.5 – 10.2 mg/dL	9.2
BUN	6 – 20 mg/dL	15
Creatinine	0.6 – 1.3 mg/dL	1.0
Glucose	70 – 100 mg/dL	85
ALT	< 35 U/L	52
AST	< 35 U/L	55
Albumin	3.4 – 5.4 g/dL	2.0
Bilirubin	0.3 – 1.9 mg/dL	4.0
Ammonia	15 – 45 mcg/dL	110

INR ………………….   2.1

Urine analysis & Lumbar puncture results are normal.

---

Question:

Which of the following treatment measures do you recommend? Select ALL that apply.

Answer:

A Volume resuscitation with Normal Saline IV infusion B Ceftriaxone empiric therapy to treat meningitis C PO Lactulose D Xifaxan E Sodium bicarbonate to alkalinize the urine

Submit Answer

Question:

Which of the following medications are used to treat hyperphosphotemia of ESRD? Select ALL that apply.

Answer:

A Calcium acetate B Renagel C Renvela D Sodium polystyrene E Lokelma

Submit Answer

Question:

DB is a 67-year-old male with ESRD on dialysis who has been on Epogen 3000 units SC three times a week for anemia of chronic renal failure. His recent labs are as follows:

Hgb …………………. 12.6 g/dL (13.5 – 16.5 g/dL for males)
Hct …………………… 38.6 % (40% – 52%)
MCV …………………. 86 fL
WBC ………………… 4.0 thous/microL
Platelets …………….. 185 thous/microL

With regards to his Epogen dosing, what would be the most appropriate course of action?

Answer:

A Continue with the same dose B Increase dose to 3600 units SQ three times a week. C Reduce dose to 2400 units SQ three times a week. D Discontinue for a few weeks and when HgB <10 g/dL, restart Epogen at a lower dose.

Submit Answer

Question:

Which of the following is NOT a suspending agent?

Answer:

A Silica Gel B Tragacanth C Hydroxyethylcellulose D Guar Gum E Methylparaben

Submit Answer

Your score:

You correctly answered out of questions.

Retake Quiz

Review Incorrect Answers

Topics Covered in Live Course

This is a list of ALL the topics covered in the coursebook and the Online video lectures.

Please note that due to time constraints, some of the topics below (covered in the coursebook and online course) will NOT be lectured on during the Live Review. 

Hypertension Hypertensive emergency Congestive Heart Failure Atrial Fibrillation Anti-Arrhythmics Anti-Coagulants Anti-platelets Thrombolytics Stroke Angina Acute Coronary Syndrome Myocardial Infarction Autonomic Nervous System Dyslipidemia Interpreting LABS Electrolytes Metabolic panels Renal and Hepatic dysfunction CBC and Anemias Asthma & COPD Nebulizers and MDIs Diabetes Mellitus Chemotherapy Osteoporosis Contraceptives Womens' health Rheumatoid Arthritis  GERD / PUD Pregnancy   Smoking Cessation Pain Management Muscle Relaxants Insomnia  Medication Safety

Patient Profiles / Inpatient cases Calculations Statistics Compounding IV Incompatibilities TPN Ulcerative Colitis Crohn's disease Irritable Bowel Syndrome Multiple Sclerosis Transplant Drugs Antibiotics Antivirals Antifungals Tuberculosis HIV  /  AIDS Immunizations Anxiety and related disorders Depression Bipolar disorder Schizophrenia Parkinson's CNS Stimulants Weight loss Alzheimer's Migraine Seizure Gout Herbals OTC Thyroid Meds Ophthalmic Meds Cystic Fibrosis Sickle Cell Disease Erectile Dysfunction